No Data
No Data
NanoViricides Bolsters Partnership Efforts - Engages Aagami Inc.
Analyzing Nanoviricides' Shift to RSV Treatments With Proactive Healthcare Analyst Dr. John Savin | NYSE-A:NNVC
Lethally RSV Infected Animals Orally Treated With NV-387 Showed Normal Lung Histology, Indicating Potential Cure
NV-387, A Broad-Spectrum Antiviral with Strong Activity Against RSV, Influenza A, Coronaviruses, Others SHELTON, CT / ACCESSWIRE / May 20, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company
NanoViricides Reports Strong Antiviral Activity of NV-387 Against RSV | NYSE-A:NNVC
12 Health Care Stocks Moving In Thursday's Intraday Session
GainersLucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 205.8% to $1.56 during Thursday's regular session. The company's market cap stands at $2.7 million. SINTX Techs (NASDAQ:SINT) sha
Nanoviricides | 10-Q: Quarterly report
No Data